-
1
-
-
55049136834
-
Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
-
Review
-
Heran B,Wong M, Heran I, Wright J. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev 2008; (4):CD003822. Review.
-
(2008)
Cochrane Database Syst Rev
, vol.4
-
-
Heran, B.1
Wong, M.2
Heran, I.3
Wright, J.4
-
2
-
-
0033979994
-
Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists
-
Song JC, White CM. Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists. Pharmacotherapy 2000;20:130-139.
-
(2000)
Pharmacotherapy
, vol.20
, pp. 130-139
-
-
Song, J.C.1
White, C.M.2
-
3
-
-
0034030466
-
Angiotensin II antagonists for hypertension: Are there differences in efficacy?
-
Conlin PR, Spence JD, Williams B, Ribeiro AB, Saito I, Benedict C, Bunt AM. Angiotensin II antagonists for hypertension: Are there differences in efficacy?AmJ Hypertens 2000;13:418-426.
-
(2000)
Am J Hypertens
, vol.13
, pp. 418-426
-
-
Conlin, P.R.1
Spence, J.D.2
Williams, B.3
Ribeiro, A.B.4
Saito, I.5
Benedict, C.6
Bunt, A.M.7
-
4
-
-
42549085390
-
Meta-Analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension
-
Xi GL, Cheng JW, Lu GC. Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension. Am J Hypertens 2008;21:546-552.
-
(2008)
Am J Hypertens
, vol.21
, pp. 546-552
-
-
Xi, G.L.1
Cheng, J.W.2
Lu, G.C.3
-
5
-
-
0042884278
-
Comparison of telmisartan versus losartan: Meta-Analysis of titration-To-Response studies
-
Smith DH, Cramer MJ, Neutel JM, Hettiarachchi R, Koval S. Comparison of telmisartan versus losartan: Meta-analysis of titration-To-Response studies. Blood Press Monit 2003;8:111-117.
-
(2003)
Blood Press Monit
, vol.8
, pp. 111-117
-
-
Smith, D.H.1
Cramer, M.J.2
Neutel, J.M.3
Hettiarachchi, R.4
Koval, S.5
-
6
-
-
0038581685
-
Prognostic value of ambulatory blood-Pressure recordings in patients with treated hypertension
-
Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. Prognostic value of ambulatory blood-Pressure recordings in patients with treated hypertension. N Engl J Med 2003;348:2407-2415.
-
(2003)
N Engl J Med
, vol.348
, pp. 2407-2415
-
-
Clement, D.L.1
De Buyzere, M.L.2
De Bacquer, D.A.3
De Leeuw, P.W.4
Duprez, D.A.5
Fagard, R.H.6
Gheeraert, P.J.7
Missault, L.H.8
Braun, J.J.9
Six, R.O.10
Van Der Niepen, P.11
O'Brien, E.12
-
8
-
-
69449100622
-
Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement
-
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009;339:b2535.
-
(2009)
BMJ
, vol.339
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
10
-
-
0026776749
-
Variance imputation for overviews of clinical trials with continuous response
-
Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992;45:769-773.
-
(1992)
J Clin Epidemiol
, vol.45
, pp. 769-773
-
-
Follmann, D.1
Elliott, P.2
Suh, I.3
Cutler, J.4
-
11
-
-
0038460302
-
The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report
-
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, JonesDW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-2572.
-
(2003)
JAMA
, vol.289
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo, Jr.J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright, Jr.J.T.10
Roccella, E.J.11
-
12
-
-
0030922816
-
Bias in meta-Analysis detected by a simple, graphical test
-
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
-
(1997)
BMJ
, vol.315
, pp. 629-634
-
-
Egger, M.1
Davey Smith, G.2
Schneider, M.3
Minder, C.4
-
13
-
-
84921702413
-
Interaction revisited: The difference between two estimates
-
Altman DG, Bland JM. Interaction revisited: The difference between two estimates. BMJ 2003;326:219.
-
(2003)
BMJ
, vol.326
, pp. 219
-
-
Altman, D.G.1
Bland, J.M.2
-
14
-
-
0033917552
-
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
-
Andersen S, TarnowL, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 2000;57:601-606.
-
(2000)
Kidney Int
, vol.57
, pp. 601-606
-
-
Andersen, S.1
Tarnow, L.2
Rossing, P.3
Hansen, B.V.4
Parving, H.5
-
15
-
-
33645068586
-
A placebo-Controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-H ambulatory blood pressure monitoring
-
Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM. A placebo-Controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-H ambulatory blood pressure monitoring. Int J Clin Pract 2006;60:391-398.
-
(2006)
Int J Clin Pract
, vol.60
, pp. 391-398
-
-
Baguet, J.P.1
Nisse-Durgeat, S.2
Mouret, S.3
Asmar, R.4
Mallion, J.M.5
-
16
-
-
0036155522
-
A comparative trial of controlled-Onset, extended-Release verapamil, enalapril, and losartan on blood pressure and heart rate changes
-
Bakris G, Sica D, Ram V, Fagan T, Vaitkus PT, Anders RJ. A comparative trial of controlled-Onset, extended-Release verapamil, enalapril, and losartan on blood pressure and heart rate changes. Am J Hypertens 2002;15:53-57.
-
(2002)
Am J Hypertens
, vol.15
, pp. 53-57
-
-
Bakris, G.1
Sica, D.2
Ram, V.3
Fagan, T.4
Vaitkus, P.T.5
Anders, R.J.6
-
17
-
-
0043172552
-
Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-Hour ambulatory blood pressure monitoring in patients with essential hypertension
-
Brunner HR, Stumpe KO, Januszewicz A. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-Hour ambulatory blood pressure monitoring in patients with essential hypertension. Clin Drug Investig 2003;23: 419-430.
-
(2003)
Clin Drug Investig
, vol.23
, pp. 419-430
-
-
Brunner, H.R.1
Stumpe, K.O.2
Januszewicz, A.3
-
18
-
-
0029817681
-
Antihypertensive efficacy of the angiotensin II AT1-Receptor antagonist losartan: Results of a randomized, double-Blind, placebo-Controlled, parallel-Group trial using 24-Hour blood pressure monitoring Ambulatory Blood Pressure Monitoring Study Group
-
Byyny RL. Antihypertensive efficacy of the angiotensin II AT1-Receptor antagonist losartan: Results of a randomized, double-Blind, placebo-Controlled, parallel-Group trial using 24-Hour blood pressure monitoring. Ambulatory Blood Pressure Monitoring Study Group. Blood Press Suppl 1996;2:71-77.
-
(1996)
Blood Press Suppl
, vol.2
, pp. 71-77
-
-
Byyny, R.L.1
-
19
-
-
0034986031
-
Antihypertensive efficacy and tolerability of low-Dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension
-
Chanudet X, De Champvallins M. Antihypertensive efficacy and tolerability of low-Dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension. Int J Clin Pract 2001;55:233-239.
-
(2001)
Int J Clin Pract
, vol.55
, pp. 233-239
-
-
Chanudet, X.1
De Champvallins, M.2
-
20
-
-
0038042008
-
Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-To-Moderate hypertension
-
Chrysant SG, Marbury TC, Robinson TD. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-To-Moderate hypertension. J Hum Hypertens 2003;17:425-432.
-
(2003)
J Hum Hypertens
, vol.17
, pp. 425-432
-
-
Chrysant, S.G.1
Marbury, T.C.2
Robinson, T.D.3
-
21
-
-
0033954240
-
Comparison of the efficacy and safety of losartan (50-100 mg) with the T-Type calcium channel blocker mibefradil (50-100 mg) in mild to moderate hypertension
-
Chung O, Hinder M, Sharma AM, Bonner G, Middeke M, Platon J, Unger T. Comparison of the efficacy and safety of losartan (50-100 mg) with the T-Type calcium channel blocker mibefradil (50-100 mg) in mild to moderate hypertension. Fundam Clin Pharmacol 2000;14:31-41.
-
(2000)
Fundam Clin Pharmacol
, vol.14
, pp. 31-41
-
-
Chung, O.1
Hinder, M.2
Sharma, A.M.3
Bonner, G.4
Middeke, M.5
Platon, J.6
Unger, T.7
-
22
-
-
0141730354
-
The antiproteinuric effect of losartan is systemic blood pressure dependent
-
Crowe AV, Howse M, Vinjamuri S, Kemp GJ, Williams PS. The antiproteinuric effect of losartan is systemic blood pressure dependent. Nephrol Dial Transplant 2003;18: 2160-2164.
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 2160-2164
-
-
Crowe, A.V.1
Howse, M.2
Vinjamuri, S.3
Kemp, G.J.4
Williams, P.S.5
-
23
-
-
34247263709
-
Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients
-
de Champlain J, Karas M, Assouline L, Nadeau R, LeBlanc AR, Dube B, Larochelle P. Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients. J Clin Hypertens (Greenwich) 2007;9:168-178.
-
(2007)
J Clin Hypertens (Greenwich)
, vol.9
, pp. 168-178
-
-
De Champlain, J.1
Karas, M.2
Assouline, L.3
Nadeau, R.4
Leblanc, A.R.5
Dube, B.6
Larochelle, P.7
-
24
-
-
18444416063
-
Comparative efficacy of valsartan and olmesartan in mild-To-Moderate hypertension: Results of 24-Hour ambulatory blood pressure monitoring
-
Destro M, Scabrosetti R, Vanasia A, Mugellini A. Comparative efficacy of valsartan and olmesartan in mild-To-Moderate hypertension: Results of 24-Hour ambulatory blood pressure monitoring. Adv Ther 2005;22:32-43.
-
(2005)
Adv Ther
, vol.22
, pp. 32-43
-
-
Destro, M.1
Scabrosetti, R.2
Vanasia, A.3
Mugellini, A.4
-
25
-
-
10344248150
-
A double-Blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mgin the treatment of mild-To-Moderate hypertension in Taiwanese patients
-
Ding PY, Chu KM, Chiang HT, Shu KH. A double-Blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mgin the treatment of mild-To-Moderate hypertension in Taiwanese patients. Int J Clin Pract Suppl 2004;125:16-22.
-
(2004)
Int J Clin Pract Suppl
, vol.125
, pp. 16-22
-
-
Ding, P.Y.1
Chu, K.M.2
Chiang, H.T.3
Shu, K.H.4
-
26
-
-
79960797566
-
Effect of valsartan, hydrochlorothiazide, and their combination on 24-H ambulatory blood pressure response in elderly patients with systolic hypertension: A ValVET substudy
-
Duprez DA, Weintraub HS, Cushman WC, Purkayastha D, Zappe D, Samuel R, Izzo JL Jr. Effect of valsartan, hydrochlorothiazide, and their combination on 24-H ambulatory blood pressure response in elderly patients with systolic hypertension: A ValVET substudy. Blood Press Monit 2011;16:186-196.
-
(2011)
Blood Press Monit
, vol.16
, pp. 186-196
-
-
Duprez, D.A.1
Weintraub, H.S.2
Cushman, W.C.3
Purkayastha, D.4
Zappe, D.5
Samuel, R.6
Izzo, Jr.J.L.7
-
27
-
-
84859892353
-
Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan: The ASSERTIVE double-Blind, randomized study
-
Düsing R, Brunel P, Baek I, Baschiera F. Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan: The ASSERTIVE double-Blind, randomized study. J Hypertens 2012;30:1029-1040.
-
(2012)
J Hypertens
, vol.30
, pp. 1029-1040
-
-
Düsing, R.1
Brunel, P.2
Baek, I.3
Baschiera, F.4
-
28
-
-
0035127162
-
A randomised, placebo-Controlled, double-Blind, crossover study of losartan and enalapril in patients with essential hypertension
-
Fagard R, Lijnen P, Pardaens K, Thijs L, VinckW. A randomised, placebo-Controlled, double-Blind, crossover study of losartan and enalapril in patients with essential hypertension. J Hum Hypertens 2001;15:161-167.
-
(2001)
J Hum Hypertens
, vol.15
, pp. 161-167
-
-
Fagard, R.1
Lijnen, P.2
Pardaens, K.3
Thijs, L.4
Vinck, W.5
-
29
-
-
33845602177
-
Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy
-
Fogari R, Zoppi A, Mugellini A, Preti P, Destro M, Rinaldi A, Derosa G. Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy. Adv Ther 2006;23:680-695.
-
(2006)
Adv Ther
, vol.23
, pp. 680-695
-
-
Fogari, R.1
Zoppi, A.2
Mugellini, A.3
Preti, P.4
Destro, M.5
Rinaldi, A.6
Derosa, G.7
-
30
-
-
41249095681
-
Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: A prospective, randomized, open-Label, blinded end point (PROBE), parallel-Arm study
-
Fogari R, Zoppi A, Mugellini A, Preti P, Destro M, Rinaldi A, Derosa G. Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: A prospective, randomized, open-Label, blinded end point (PROBE), parallel-arm study. Curr Ther Res Clin Exp 2008;69:1-15.
-
(2008)
Curr Ther Res Clin Exp
, vol.69
, pp. 1-15
-
-
Fogari, R.1
Zoppi, A.2
Mugellini, A.3
Preti, P.4
Destro, M.5
Rinaldi, A.6
Derosa, G.7
-
31
-
-
0842264751
-
Freehand three-Dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-To-Moderate hypertension: A multicentre study
-
Galzerano D, Tammaro P, Cerciello A, Breglio R, Mallardo M, Lama D, Tuccillo B, Capogrosso P. Freehand three-Dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-To-Moderate hypertension: A multicentre study. J Hum Hypertens 2004;18:53-59.
-
(2004)
J Hum Hypertens
, vol.18
, pp. 53-59
-
-
Galzerano, D.1
Tammaro, P.2
Cerciello, A.3
Breglio, R.4
Mallardo, M.5
Lama, D.6
Tuccillo, B.7
Capogrosso, P.8
-
32
-
-
29244474389
-
Three-Dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study
-
Galzerano D, Tammaro P, del Viscovo L, Lama D, Galzerano A, Breglio R, Tuccillo B, Paolisso G, Capogrosso P. Three-Dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study. Am J Hypertens 2005;18: 1563-1569.
-
(2005)
Am J Hypertens
, vol.18
, pp. 1563-1569
-
-
Galzerano, D.1
Tammaro, P.2
Del Viscovo, L.3
Lama, D.4
Galzerano, A.5
Breglio, R.6
Tuccillo, B.7
Paolisso, G.8
Capogrosso, P.9
-
33
-
-
0036492008
-
Changes in pain perception during treatment with angiotensin converting enzyme-Inhibitors and angiotensin II type 1 receptor blockade
-
Guasti L, Zanotta D, Diolisi A, Garganico D, Simoni C, Gaudio G, Grandi AM, Venco A. Changes in pain perception during treatment with angiotensin converting enzyme-Inhibitors and angiotensin II type 1 receptor blockade. J Hypertens 2002;20: 485-491.
-
(2002)
J Hypertens
, vol.20
, pp. 485-491
-
-
Guasti, L.1
Zanotta, D.2
Diolisi, A.3
Garganico, D.4
Simoni, C.5
Gaudio, G.6
Grandi, A.M.7
Venco, A.8
-
34
-
-
25444506196
-
Administration time-Dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects
-
Hermida RC, Calvo C, Ayala DE, Mojon A, Rodriguez M, Chayan L, Lopez JE, Fontao MJ, Soler R, Fernandez JR. Administration time-Dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int 2005;22:755-776.
-
(2005)
Chronobiol Int
, vol.22
, pp. 755-776
-
-
Hermida, R.C.1
Calvo, C.2
Ayala, D.E.3
Mojon, A.4
Rodriguez, M.5
Chayan, L.6
Lopez, J.E.7
Fontao, M.J.8
Soler, R.9
Fernandez, J.R.10
-
35
-
-
34548825662
-
Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension
-
Hermida RC, Ayala DE, Fernandez JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 2007;50:715-722.
-
(2007)
Hypertension
, vol.50
, pp. 715-722
-
-
Hermida, R.C.1
Ayala, D.E.2
Fernandez, J.R.3
Calvo, C.4
-
36
-
-
60549113548
-
Administration-Timedependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients
-
Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration-timedependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int 2009;26:61-79.
-
(2009)
Chronobiol Int
, vol.26
, pp. 61-79
-
-
Hermida, R.C.1
Ayala, D.E.2
Chayan, L.3
Mojon, A.4
Fernandez, J.R.5
-
37
-
-
55449135822
-
A randomized trial of the effect of an angiotensin II receptor blocker SR47436 (irbesartan) on 24-Hour blood pressure in patients with essential hypertension
-
Kawano Y, Sato Y, Yoshinaga K. A randomized trial of the effect of an angiotensin II receptor blocker SR47436 (irbesartan) on 24-Hour blood pressure in patients with essential hypertension. Hypertens Res 2008;31:1753-1763.
-
(2008)
Hypertens Res
, vol.31
, pp. 1753-1763
-
-
Kawano, Y.1
Sato, Y.2
Yoshinaga, K.3
-
38
-
-
0034032809
-
Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea
-
Kraiczi H, Hedner J, PekerY, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000;161:1423-1428.
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 1423-1428
-
-
Kraiczi, H.1
Hedner, J.2
Pekery Grote, L.3
-
39
-
-
1642540951
-
Effects of the combination of low-Dose nifedipine GITS 20 mg and losartan 50 mg in patients with mild to moderate hypertension
-
Kuschnir E, Bendersky M, Resk J, Panart MS, Guzman L, Plotquin Y, Grassi G, Mancia G, Wagener G. Effects of the combination of low-Dose nifedipine GITS 20 mg and losartan 50 mg in patients with mild to moderate hypertension. J Cardiovasc Pharmacol 2004;43:300-305.
-
(2004)
J Cardiovasc Pharmacol
, vol.43
, pp. 300-305
-
-
Kuschnir, E.1
Bendersky, M.2
Resk, J.3
Panart, M.S.4
Guzman, L.5
Plotquin, Y.6
Grassi, G.7
Mancia, G.8
Wagener, G.9
-
40
-
-
0033391893
-
A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: A placebo-Controlled, forced titration study
-
Candesartan/Losartan study investigators
-
Lacourciere Y, Asmar R. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: A placebo-Controlled, forced titration study. Candesartan/Losartan study investigators. Am J Hypertens 1999;12: 1181-1187.
-
(1999)
Am J Hypertens
, vol.12
, pp. 1181-1187
-
-
Lacourciere, Y.1
Asmar, R.2
-
41
-
-
32244449465
-
A multicenter, 14-Week study of telmisartan and ramipril in patients with mild-To-Moderate hypertension using ambulatory blood pressure monitoring
-
Lacourciere Y, Neutel JM, Davidai G, Koval S. A multicenter, 14-Week study of telmisartan and ramipril in patients with mild-To-Moderate hypertension using ambulatory blood pressure monitoring. Am J Hypertens 2006;19:104-112.
-
(2006)
Am J Hypertens
, vol.19
, pp. 104-112
-
-
Lacourciere, Y.1
Neutel, J.M.2
Davidai, G.3
Koval, S.4
-
42
-
-
0033784560
-
A prospective, randomized, open-Label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring
-
Littlejohn T, MroczekW, Marbury T, VanderMaelen CP, Dubiel RF. A prospective, randomized, open-Label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Can J Cardiol 2000;16:1123-1132.
-
(2000)
Can J Cardiol
, vol.16
, pp. 1123-1132
-
-
Littlejohn, T.1
Mroczekw Marbury, T.2
Vandermaelen, C.P.3
Dubiel, R.F.4
-
43
-
-
32244447763
-
Indapamide SR versus candesartan and amlodipine in hypertension: The X-CELLENT Study
-
London G, Schmieder R, Calvo C, Asmar R. Indapamide SR versus candesartan and amlodipine in hypertension: The X-CELLENT Study. Am J Hypertens 2006;19: 113-121.
-
(2006)
Am J Hypertens
, vol.19
, pp. 113-121
-
-
London, G.1
Schmieder, R.2
Calvo, C.3
Asmar, R.4
-
44
-
-
0344289511
-
ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-To-Moderate hypertension
-
Mallion J, Siche J, Lacourciere Y. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-To-Moderate hypertension. J Hum Hypertens 1999;13:657-664.
-
(1999)
J Hum Hypertens
, vol.13
, pp. 657-664
-
-
Mallion, J.1
Siche, J.2
Lacourciere, Y.3
-
45
-
-
70450200272
-
Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-Stroke patients
-
Matsumoto S, Shimodozono M, Miyata R, Kawahira K. Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-Stroke patients. Brain Inj 2009;23:1065-1072.
-
(2009)
Brain Inj
, vol.23
, pp. 1065-1072
-
-
Matsumoto, S.1
Shimodozono, M.2
Miyata, R.3
Kawahira, K.4
-
46
-
-
85027932825
-
Combining blockers of the renin-Angiotensin system or increasing the dose of an angiotensin II receptor antagonist in proteinuric patients: A randomized triple-Crossover study
-
Meier P, MaillardMP, Meier JR, Tremblay S, Gauthier T, Burnier M. Combining blockers of the renin-Angiotensin system or increasing the dose of an angiotensin II receptor antagonist in proteinuric patients: A randomized triple-Crossover study. J Hypertens 2011;29:1228-1235.
-
(2011)
J Hypertens
, vol.29
, pp. 1228-1235
-
-
Meier, P.1
Maillard, M.P.2
Meier, J.R.3
Tremblay, S.4
Gauthier, T.5
Burnier, M.6
-
47
-
-
0036015042
-
A comparison of candesartan, felodipine, and their combination in the treatment of elderly patients with systolic hypertension
-
Morgan T, Anderson A. A comparison of candesartan, felodipine, and their combination in the treatment of elderly patients with systolic hypertension. Am J Hypertens 2002;15:544-549.
-
(2002)
Am J Hypertens
, vol.15
, pp. 544-549
-
-
Morgan, T.1
Anderson, A.2
-
49
-
-
7944233130
-
Effects of valsartan and nifedipine coat-Core on systemic arterial stiffness in hypertensive patients
-
Munakata M, Nagasaki A, Nunokawa T, Sakuma T, Kato H, Yoshinaga K, Toyota T. Effects of valsartan and nifedipine coat-Core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004;17:1050-1055.
-
(2004)
Am J Hypertens
, vol.17
, pp. 1050-1055
-
-
Munakata, M.1
Nagasaki, A.2
Nunokawa, T.3
Sakuma, T.4
Kato, H.5
Yoshinaga, K.6
Toyota, T.7
-
50
-
-
0030814394
-
Valsartan, a new angiotensin II antagonist: Antihypertensive effects over 24 hours
-
Discussion 367-368
-
Neutel J,Weber M, Pool J, Smith D, Fitzsimmons S, Chiang YT, Gatlin M. Valsartan, a new angiotensin II antagonist: Antihypertensive effects over 24 hours. Clin Ther 1997; 19:447-458; Discussion 367-368.
-
(1997)
Clin Ther
, vol.19
, pp. 447-458
-
-
Neutel, J.1
Weber, M.2
Pool, J.3
Smith, D.4
Fitzsimmons, S.5
Chiang, Y.T.6
Gatlin, M.7
-
51
-
-
0036750076
-
Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements
-
Neutel JM, Elliott WJ, Izzo JL, Chen CL, Masonson HN. Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements. J Clin Hypertens (Greenwich) 2002;4: 325-331.
-
(2002)
J Clin Hypertens (Greenwich)
, vol.4
, pp. 325-331
-
-
Neutel, J.M.1
Elliott, W.J.2
Izzo, J.L.3
Chen, C.L.4
Masonson, H.N.5
-
52
-
-
0041589771
-
Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-To-Moderate essential hypertension-A randomised ABPM study
-
Neutel JM, Kolloch RE, Plouin PF, Meinicke TW, Schumacher H. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-To-Moderate essential hypertension-a randomised ABPM study. J Hum Hypertens 2003;17:569-575.
-
(2003)
J Hum Hypertens
, vol.17
, pp. 569-575
-
-
Neutel, J.M.1
Kolloch, R.E.2
Plouin, P.F.3
Meinicke, T.W.4
Schumacher, H.5
-
53
-
-
73849138948
-
A randomized, double-Blind, four-Arm parallel-Group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: The REZALT study
-
Ogihara T, Saruta T, Shimada K, Kuramoto K. A randomized, double-Blind, four-arm parallel-Group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: The REZALT study. Hypertens Res 2009;32:1148-1154.
-
(2009)
Hypertens Res
, vol.32
, pp. 1148-1154
-
-
Ogihara, T.1
Saruta, T.2
Shimada, K.3
Kuramoto, K.4
-
54
-
-
75149195876
-
Maintenance of blood-Pressure-Lowering effect following a missed dose of aliskiren, irbesartan or ramipril: Results of a randomized, double-Blind study
-
Palatini P, Jung W, Shlyakhto E, Botha J, Bush C, Keefe DL. Maintenance of blood-Pressure-Lowering effect following a missed dose of aliskiren, irbesartan or ramipril: Results of a randomized, double-Blind study. J Hum Hypertens 2010;24:93-103.
-
(2010)
J Hum Hypertens
, vol.24
, pp. 93-103
-
-
Palatini, P.1
Jung, W.2
Shlyakhto, E.3
Botha, J.4
Bush, C.5
Keefe, D.L.6
-
55
-
-
77955253587
-
Effectiveness of barnidipine 10 or 20 mg plus losartan 50-Mg combination versus losartan 100-Mg monotherapy in patients with essential hypertension not controlled by losartan 50-Mg monotherapy: A 12-Week, multicenter, randomized, open-Label, parallel-Group study
-
Parati G, Giglio A, Lonati L, Destro M, Ricci AR, Cagnoni F, Pini C, Venco A, Maresca AM, Monza M, Grandi AM, Omboni S. Effectiveness of barnidipine 10 or 20 mg plus losartan 50-Mg combination versus losartan 100-Mg monotherapy in patients with essential hypertension not controlled by losartan 50-Mg monotherapy: A 12-Week, multicenter, randomized, open-Label, parallel-Group study. Clin Ther 2010;32:1270-1284.
-
(2010)
Clin Ther
, vol.32
, pp. 1270-1284
-
-
Parati, G.1
Giglio, A.2
Lonati, L.3
Destro, M.4
Ricci, A.R.5
Cagnoni, F.6
Pini, C.7
Venco, A.8
Maresca, A.M.9
Monza, M.10
Grandi, A.M.11
Omboni, S.12
-
56
-
-
0031890860
-
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients
-
Pechere-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J Hypertens 1998;16:385-393.
-
(1998)
J Hypertens
, vol.16
, pp. 385-393
-
-
Pechere-Bertschi, A.1
Nussberger, J.2
Decosterd, L.3
Armagnac, C.4
Sissmann, J.5
Bouroudian, M.6
Brunner, H.R.7
Burnier, M.8
-
57
-
-
0142093996
-
Central and peripheralhemodynamic effects of losartan and in combination with hydrochlorothiazide in mild to moderate essential hypertension
-
Podzolkov VI, BulatovVA, Son EA, OsI. Central and peripheralhemodynamic effects of losartan and in combination with hydrochlorothiazide in mild to moderate essential hypertension. Blood Press 2003;12:239-245.
-
(2003)
Blood Press
, vol.12
, pp. 239-245
-
-
Podzolkov, V.I.1
Bulatov, V.A.2
Son, E.A.3
Os, I.4
-
58
-
-
12344313951
-
A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension
-
Poirier L, de Champlain J, Larochelle P, Lamarre-Cliche M, Lacourciere Y. A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension. Blood PressMonit 2004;9:231-236.
-
(2004)
Blood PressMonit
, vol.9
, pp. 231-236
-
-
Poirier, L.1
De Champlain, J.2
Larochelle, P.3
Lamarre-Cliche, M.4
Lacourciere, Y.5
-
59
-
-
69049110017
-
24-Hour and nighttime blood pressuremonitoring in type 2 diabetic hypertensive patients
-
Povedano ST, GarciaDeLa Villa G. 24-Hour and nighttime blood pressuremonitoring in type 2 diabetic hypertensive patients. J Clin Hypertens (Greenwich) 2009;11:426-431.
-
(2009)
J Clin Hypertens (Greenwich)
, vol.11
, pp. 426-431
-
-
Povedano, S.T.1
Garciadela Villa, G.2
-
60
-
-
0033913424
-
Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: Feasibility, agreement, and reproducibility of blood pressure response
-
Ragot S, Genes N, Vaur L, Herpin D. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: Feasibility, agreement, and reproducibility of blood pressure response. Am J Hypertens 2000;13: 632-639.
-
(2000)
Am J Hypertens
, vol.13
, pp. 632-639
-
-
Ragot, S.1
Genes, N.2
Vaur, L.3
Herpin, D.4
-
61
-
-
34447253750
-
Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-Reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension
-
Rajagopalan S, Zannad F, Radauceanu A, Glazer R, Jia Y, PrescottMF, Kariisa M, Pitt B. Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-Reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension. Am J Cardiol 2007;100: 222-226.
-
(2007)
Am J Cardiol
, vol.100
, pp. 222-226
-
-
Rajagopalan, S.1
Zannad, F.2
Radauceanu, A.3
Glazer, R.4
Jia, Y.5
Prescott, M.F.6
Kariisa, M.7
Pitt, B.8
-
62
-
-
0036833657
-
Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: A randomized double-Blind placebo-Controlled crossover study
-
Sasso FC, Carbonara O, Persico M, Iafusco D, Salvatore T, D'Ambrosio R, Torella R, Cozzolino D. Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: A randomized double-Blind placebo-Controlled crossover study. Diabetes Care 2002;25:1909-1913.
-
(2002)
Diabetes Care
, vol.25
, pp. 1909-1913
-
-
Sasso, F.C.1
Carbonara, O.2
Persico, M.3
Iafusco, D.4
Salvatore, T.5
D'Ambrosio, R.6
Torella, R.7
Cozzolino, D.8
-
63
-
-
12744269551
-
Use of 24-Hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: A comparison of olmesartanmedoxomil, losartan potassium, valsartan, and irbesartan
-
Smith DH,Dubiel R, Jones M. Use of 24-Hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: A comparison of olmesartanmedoxomil, losartan potassium, valsartan, and irbesartan. Am J Cardiovasc Drugs 2005;5:41-50.
-
(2005)
Am J Cardiovasc Drugs
, vol.5
, pp. 41-50
-
-
Smith, D.H.1
Dubiel, R.2
Jones, M.3
-
64
-
-
0036813050
-
Assessment of drug effects on blood pressure and pulse pressure using clinic, home and ambulatory measurements
-
Stergiou GS, Efstathiou SP, Skeva II, Baibas NM, Kalkana CB, Mountokalakis TD. Assessment of drug effects on blood pressure and pulse pressure using clinic, home and ambulatory measurements. J Hum Hypertens 2002;16:729-735.
-
(2002)
J Hum Hypertens
, vol.16
, pp. 729-735
-
-
Stergiou, G.S.1
Efstathiou, S.P.2
Skeva, I.I.3
Baibas, N.M.4
Kalkana, C.B.5
Mountokalakis, T.D.6
-
65
-
-
0141753977
-
Blood pressure- and pulse pressure-Lowering effects, trough: Peak ratio and smoothness index of telmisartan compared with lisinopril
-
Stergiou GS, Efstathiou SP, Roussias LG, Mountokalakis TD. Blood pressure- and pulse pressure-Lowering effects, trough:peak ratio and smoothness index of telmisartan compared with lisinopril. J Cardiovasc Pharmacol 2003;42:491-496.
-
(2003)
J Cardiovasc Pharmacol
, vol.42
, pp. 491-496
-
-
Stergiou, G.S.1
Efstathiou, S.P.2
Roussias, L.G.3
Mountokalakis, T.D.4
-
66
-
-
43449139148
-
Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: Results from the randomized, double-Blind, crossover GENRES Study
-
Suonsyrja T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Donner K, Strandberg T, Tikkanen I, Tilvis R, Pentikainen PJ, Kontula K, Hiltunen TP. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: Results from the randomized, double-Blind, crossover GENRES Study. J Hypertens 2008;26:1250-1256.
-
(2008)
J Hypertens
, vol.26
, pp. 1250-1256
-
-
Suonsyrja, T.1
Hannila-Handelberg, T.2
Paavonen, K.J.3
Miettinen, H.E.4
Donner, K.5
Strandberg, T.6
Tikkanen, I.7
Tilvis, R.8
Pentikainen, P.J.9
Kontula, K.10
Hiltunen, T.P.11
-
67
-
-
0031679918
-
Effects of losartan on hypertension and left ventricular mass: A long-Term study
-
Tedesco MA, Ratti G, Aquino D, Limongelli G, di Salvo G, Mennella S, Galzerano D, Iarussi D, Iacono A. Effects of losartan on hypertension and left ventricular mass: A long-Term study. J Hum Hypertens 1998;12:505-510.
-
(1998)
J Hum Hypertens
, vol.12
, pp. 505-510
-
-
Tedesco, M.A.1
Ratti, G.2
Aquino, D.3
Limongelli, G.4
Di Salvo, G.5
Mennella, S.6
Galzerano, D.7
Iarussi, D.8
Iacono, A.9
-
68
-
-
44649196548
-
Aldosterone escape with diuretic or angiotensin-Converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension
-
Ubaid-Girioli S, Ferreira-Melo SE, Souza LA, Nogueira EA, Yugar-Toledo JC, Coca A, Moreno H Jr. Aldosterone escape with diuretic or angiotensin-Converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension. J Clin Hypertens (Greenwich) 2007;9:770-774.
-
(2007)
J Clin Hypertens (Greenwich)
, vol.9
, pp. 770-774
-
-
Ubaid-Girioli, S.1
Ferreira-Melo, S.E.2
Souza, L.A.3
Nogueira, E.A.4
Yugar-Toledo, J.C.5
Coca, A.6
Moreno, Jr.H.7
-
69
-
-
0028942349
-
Blood pressure effects of the angiotensin II receptor blocker, losartan
-
Weber MA, Byyny RL, Pratt JH, Faison EP, Snavely DB, Goldberg AI, Nelson EB. Blood pressure effects of the angiotensin II receptor blocker, losartan. Arch Intern Med 1995;155:405-411.
-
(1995)
Arch Intern Med
, vol.155
, pp. 405-411
-
-
Weber, M.A.1
Byyny, R.L.2
Pratt, J.H.3
Faison, E.P.4
Snavely, D.B.5
Goldberg, A.I.6
Nelson, E.B.7
-
70
-
-
79952275464
-
Arandomized double-Blind, forced-Titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension
-
Weir MR,PunziHA, Flack JM, Stoakes KA, Chavanu KJ, LiW, Dubiel R.Arandomized, double-Blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension. Postgrad Med 2011;123:80-87.
-
(2011)
Postgrad Med
, vol.123
, pp. 80-87
-
-
Weir, M.R.1
Punzi, H.A.2
Flack, J.M.3
Stoakes, K.A.4
Chavanu, K.J.5
Li, W.6
Dubiel, R.7
-
71
-
-
0035216168
-
Evaluation of the 24-Hour blood pressure effects of eprosartan in patients with systemic hypertension
-
White WB,Anwar YA, Mansoor GA, Sica DA. Evaluation of the 24-Hour blood pressure effects of eprosartan in patients with systemic hypertension. Am J Hypertens 2001;14:1248-1255.
-
(2001)
Am J Hypertens
, vol.14
, pp. 1248-1255
-
-
White, W.B.1
Anwar, Y.A.2
Mansoor, G.A.3
Sica, D.A.4
-
72
-
-
1842562367
-
Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: Impact on the early morning period
-
White WB, Lacourciere Y, Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: Impact on the early morning period. Am J Hypertens 2004;17:347-353.
-
(2004)
Am J Hypertens
, vol.17
, pp. 347-353
-
-
White, W.B.1
Lacourciere, Y.2
Davidai, G.3
-
73
-
-
79953239152
-
Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension
-
White WB,Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension 2011;57:413-420.
-
(2011)
Hypertension
, vol.57
, pp. 413-420
-
-
White, W.B.1
Weber, M.A.2
Sica, D.3
Bakris, G.L.4
Perez, A.5
Cao, C.6
Kupfer, S.7
-
74
-
-
29244484441
-
The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I)
-
Williams B, Gosse P,Lowe L, Harper R. The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I). J Hypertens 2006;24:193-200.
-
(2006)
J Hypertens
, vol.24
, pp. 193-200
-
-
Williams, B.1
Gosse Plowe, L.2
Harper, R.3
-
75
-
-
23044453625
-
Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy
-
Yasuda G, Ando D, Hirawa N, Umemura S, Tochikubo O. Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy. Diabetes Care 2005;28: 1862-1868.
-
(2005)
Diabetes Care
, vol.28
, pp. 1862-1868
-
-
Yasuda, G.1
Ando, D.2
Hirawa, N.3
Umemura, S.4
Tochikubo, O.5
-
76
-
-
84864717733
-
Trends in prevalence, awareness, management, and control of hypertension among United States adults 1999 to 2010
-
Guo F, He D, ZhangW,Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 2012;60:599-606.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 599-606
-
-
Guo, F.1
He, D.2
Zhang, W.3
Walton, R.G.4
-
78
-
-
61649091385
-
Combination therapy versus monotherapy in reducing blood pressure: Meta-Analysis on 11,000 participants from 42 trials
-
Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: Meta-analysis on 11,000 participants from 42 trials. Am J Med 2009;122:290-300.
-
(2009)
Am J Med
, vol.122
, pp. 290-300
-
-
Wald, D.S.1
Law, M.2
Morris, J.K.3
Bestwick, J.P.4
Wald, N.J.5
-
79
-
-
84862119222
-
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
-
Perk J,DeBacker G, Gohlke H, GrahamI, Reiner Z, VerschurenM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte op Reimer WJ, Vrints C,Wood D, Zamorano JL, Zannad F. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635-1701.
-
(2012)
Eur Heart J
, vol.33
, pp. 1635-1701
-
-
Perk, J.1
Debacker, G.2
Gohlke, H.3
Grahami Reiner, Z.4
Verschurenm Albus, C.5
Benlian, P.6
Boysen, G.7
Cifkova, R.8
Deaton, C.9
Ebrahim, S.10
Fisher, M.11
Germano, G.12
Hobbs, R.13
Hoes, A.14
Karadeniz, S.15
Mezzani, A.16
Prescott, E.17
Ryden, L.18
Scherer, M.19
Syvanne, M.20
more..
-
80
-
-
0037490085
-
Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials
-
Law MR,Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials. BMJ 2003; 326:1427.
-
(2003)
BMJ
, vol.326
, pp. 1427
-
-
Law, M.R.1
Wald, N.J.2
Morris, J.K.3
Jordan, R.E.4
-
82
-
-
0032840006
-
Losartan was no better than placebo
-
Messerli FH. . . . and losartan was no better than placebo. J Hum Hypertens 1999;13: 649-650.
-
(1999)
J Hum Hypertens
, vol.13
, pp. 649-650
-
-
Messerli, F.H.1
-
83
-
-
0032746436
-
Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay
-
Belz GG, Butzer R, Kober S, Mang C, Mutschler E. Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay. Clin Pharmacol Ther 1999;66:367-373.
-
(1999)
Clin Pharmacol Ther
, vol.66
, pp. 367-373
-
-
Belz, G.G.1
Butzer, R.2
Kober, S.3
Mang, C.4
Mutschler, E.5
-
84
-
-
0033025045
-
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists
-
Mazzolai L, Maillard M, Rossat J, Nussberger J, Brunner HR, Burnier M. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Hypertension 1999;33:850-855
-
(1999)
Hypertension
, vol.33
, pp. 850-855
-
-
Mazzolai, L.1
Maillard, M.2
Rossat, J.3
Nussberger, J.4
Brunner, H.R.5
Burnier, M.6
|